Am. J. Physiol. 200 (6) : 1296-r 300. 1 g6 1 .-The nucleating properties of various collagens have been tested by determining quantitatively the minimum ion product, Ca times P, required to form calcium phosphate crystals. While most collagens require a product of 35 (mg%)2 or greater for calcium phosphate to precipitate, some collagens extracted from tendon induce mineralization at a product of 16 (mg%)2. Plasma ultrafiltrate contains one or more substances which increase this minimum ion product, and therefore inhibit calcium phosphate nucleation. These substances are inactivated by alkaline phosphatase. Finally, polyphosphates, both organic and inorganic, are highly inhibitory to calcium phosphate nucleation and precipitation.
It is therefore suggested that at least two mechanisms may be necessary for a tissue to mineralize: I) the formation of a nucleating collagen and 2) the presence of phosphatase for the local destruction of the inhibitor(s) present in plasma.
I N RECENT YEARS, an important clarification of the mechanisms underlying biological calcification has occurred.
It has been established that the extracellular fluids are supersaturated with respect to bone mineral, that the concentrations of calcium, inorganic phosphate, and hydroxyl ions are sufficiently high to support the growth of bone mineral crystals once the initial crystals are formed. Fortunately, however, the concentrations of these ions are not high enough to precipitate spontaneously.
Some seeding mechanism seems required to initiate crystallization ( I ). An impressive body of evidence has now accumulated (1) (2) (3) (4) (5) (6) (7) (8) which suggests that collagen (or some moiety associated with collagen) may possess the unique and specific property of inducing crystal nuclei to form in otherwise metastable solutions of calcium phosphate.
In fact, certain collagens have been shown to nucleate crystal formation in solutions physiological with respect to ionic strength, pH, temperature, and calcium inorganic phosphate ion products (3, 7 were sufficiently large to be easily demonstrable.
The system is not sufficiently understood at the present time to ascribe theoretical significance to the FP. As seen in Table I product below 30. This suggests, as proposed earlier (2) , that the solubility product of CaHP04*2H20 must be exceeded for uncatalyzed precipitation to occur. Nonetheless, the case for this substance as an obligatory intermediate in solid formation
is not yet proven. In any event, while solutions having an ion product of 30 are supersaturated, with respect to solid-phase calcium phosphate at pH 7.4, there is reason to question whether the metastability of such solutions would ever break down unless a catalyst such as collagen or a seed crystal is added.
Various collagen preparations were added (2 mg/flask) to a series of solutions incubated for 3 days. Some preparations, which we will call cLactive", lowered the FP below 30; others, "inactive", did not. The incubation period of 3 days was chosen to minimize the effects of bacterial growth which, in the case of serum ultrafiltrates, was a serious problem despite the use of thymol. Later, antibiotics obviated this problem. To determine the influence of blood constituents, I ml of plasma ultrafiltrate was added to a series of x0. uct, Ca++ X Pi, in (mgYJ2 incubation lowered the FP to a minimum of 30 (mg %)". The addition of most collagen preparations to solutions incubated for 3 days gave FP's between these two uncatalyzed control values. Among the preparations found to be in this group were: a) collagen extracted from calf skin with 0.45 M NaCl, and precipitated by dialyzing against water (I 4); b) collagen extracted in the same way, but precipitated by heating to 37 C (I 4) ; c) collagen extracted in the same way, but dialyzed against phosphate buffer and purified with trichloroacetic acid and ethanol (14) ; d) collagen obtained from Nutritional Biochemical Corporation, extracted from tendon with phosphate buffer and KC1 (15).
However, two collagen preparations seemed to be catalytically active, lowering the FP to 16 (mg %)2, a product in the physiological range. These preparations were: 1) collagen obtained from Sigma Chemical Company, extracted from tendon according to technique (I 5). This collagen, upon analysis, has proved to be Ca-free. 2) A second batch of thje collagen obtained from Nutritional Biochemical Corporation. A typical experiment demonstrating the catalytic effects of an active collagen is given in Fig. I .
Having on hand a supply of active collagens, an attempt was next made to test body fluids for the presence of some substance which can inhibit the nucleation process. First, the FP was determined in several series, each containing 2 mg of active collagen and, in addition, I ml of ultrafiltrate of dog plasma. The presence of plasma ultrafiltrate was striking; the FP was raised from 16 to 34 (mg Y)2. If, however, the plasma was incubated for 2 hr at 37 C with phosphatase (I mg/ml, 15,000 unit/ml, intestinal alkaline phosphatase, Mann Research Laboratory) prior to ultrafiltration, "much of the inhibitory action was destroyed. Such ultrafiltrates raised the FP from the usual 16 to only 23 (mg Yo)2, an increase of doubtful statistical significance. These data are assembled in Table 2 .
Such results suggested that the inhibitory action might be concentration-dependent.
Also the question is raised whether the alkaline phosphatase, normally present in serum, might not also inactivate the inhibitor if given a chance to act. Accordingly, a large single batch of dog serum was divided into three parts. One part was ultrafiltered at 4 C to minimize enzyme action. A second part was made 0.01 M in KCN prior to ultrafiltration.
KCN is reported (16) to inhibit the "alkaline" phosphatases but not "acid" phosphatase.
In separate experiments, this concentration of KCN was shown to have no effect on the nucleating system, per se. Finally, the third part of the serum was ultrafiltered for several hours at 37 C to maximize phosphatase action. All three ul trafiltrates were then tested, in several dilutions, for their ability to inhibit nucleation by collagen. The results are assembled in Table 3 and confirm both the concentration dependency of the inhibitor substance and its susceptibility to the action of phosphatase.
To determine whether the circulating inhibitor was species-specific, a few studies were conducted employing ultrafiltrates of beef and human plasma. In every case the FP was markedly raised. Furthermore, incubation of human plasma with phosphatase prior to ultrafiltration removed most of the inhibitory action. A typical experiment is illustrated in Fig. 2 .
The apparent sensitivity of the inhibitor to phosphatase ( 7) I is interesting, in view of the earli .er demonstra tion that certain phosphate esters are inhibitory to the mineralization of rachitic rat cartilage and the precipitation of insoluble calcium salts. To investigate this further, a series of phosphate esters was studied for its influence on the FP in collagen-catalyzed solutions. The results are assembled in Table 4 . The FP was not significantly increased by any of the following monophosphate esters studied at a concentration of IO-~ M or less: phosphoethanolamine, glycerophosphate, phosphocholine, creatine phosphate, diphosphopyridine nucleotide (DPN), triphosphopyridine nucleotide (TPN), and adenosinemonophosphate (AMP). Incidentally, heparin and chondroitin sulfate were similarly ineffective. The polyphosphates, however, were generally much more effective, some raising the FP when present in concentrations as low as In view of the report (I 8) of the occurrence in normal urine of some material inhibitory to the mineralization of rachitic rat cartilage, a few preliminary experiments were performed in which I ml of ultrafiltered urine (adjusted to pH 7.4) was added to I 0.5 ml of collagen-catalyzed solution. In these few experiments the FP was greatly increased. Apparently in the presence of urine the FP was over 80 (mg %)", the highest product tested.
DISCUSSION
It is evident, that considerable effort will be required to clarify the region of metastability of calcium-phosphate ' solutions and the factors which destroy the metastability of such solutions. In the present experiments, merely in- creasing the time of incubation from 3 to 5 days reduced the spontaneous (no collagen) FP from 50 to 30 (mg %)2. However, thus far, spontaneous crystal formation (at 37 G P = 0.16, and pH 7.4) has not been observed at products below 30 C. Under similar conditions, almost any collagen preparation having normal 640-A spacing (2) (3) (4) (5) (6) (7) (8) will, after a g-day incubation, induce crystal formation in solutions having ion-products in the range 30-40 (mg %)? To our knowledge, only freshly demineralized dentin (3) and, in the present instance, two commercial collagens, have successfully induced crystal formation at FP's of 20 or less. Crystals of hydroxyapatite can, of course, destroy metastability at similarly low ion products, and the question naturally arises whether the active collagens are merely those contaminated with pre-existing crystals. This question is difficult to answer categorically. However, such contamination seems unlikely for these reasons: a) dentin, merely on standing, loses its nucleating properties (3). b) All active preparations have been analyzed carefully and are calcium-free, at least to the limit of detectability of about o. I ppm. c) Two of the active preparations are from tendon, a tissue not normally calcified and yet prepared in a manner similar to two inactive preparations.
Thus it seems that some property associated with certain collagens is specific in its ability to induce new crystal formation.
Earlier, it was noted that the spontaneous conversion of active dentin to inactive dentin was accompanied by a disappearance of reactive e-amino groups (as measured by coupling with dinitrofluorobenzine) (3). Indeed, in the present experiments, the active collagens have a higher percentage of reactive r-amino groups (ca 80 %) than do the inactive collagens (ca. 50-60 %).a Yet, these differences are not striking and the observations represent merely a correlation and donot establish a cause-andeffect relationship.
Despite all the uncertainties concerning I) whether collagen in vivo is responsible for the induction of the formation of bone mineral, 2) what property or grouping inherent in certain collagens is responsible for their ability to destroy the metastability calcium-phosphate solutions, and 3) whether active collagens in vitro represent a true model of biological calcification, the model system seems to be an adequate means by which to establish the existence in the circulation of a substance or substances which are strongly inhibitory to the nucleation of calcium phosphate crystals in general.
The experimental evidence on this point is quite straightforward.
Ultrafiltrates of plasma incubated with phosphatase did not interfere significantly with nucleation in the model system. Incubation of plasma with KCN, which bv itself did not interfere with nucleation, resulted in a partial inhibition of phosphatase, and the ultrafiltrates subsequently showed moderate interference with nucleation.
More complete but nonspecific blocking (4 C) of all phosphatase action resulted in ultrafiltrates which were strongly inhibitory to the nucleation process. Finally, the addition of small amounts of polyphosphates and of urine ultrafiltrates was also strongly inhibitory, raising the FP in many instances to 60 and even over 80, much higher than the point of spontaneous precipitation. Thus, it appears that there occurs in plasma one or more phosphate esters which exert a powerful deterrent action to the formation of new crystals of bone mineral. Since the phosphatase normally found in serum, given time, seems to inactivate the inhibitor, it is attractive to conclude that the ester must be continuously produced by some tissue or tissues and continuously supplied to the circulation.
In fact, since the inhibitor is ultrafiltrable and since a similar substance appears in urine, it is conceivable that much of the urinary inhibitor is derived from the blood by glomerular filtration. This situation would explain the failure of sera taken from patients with renal insufficiency to calcify rachitic rat cartilage It is of interest to note that long-chain polyphosphates are more effective in preventing boiler scale than are the ring polymers (2 I ). Similar differences were observed here in the inhibition of nucleation of calcium phosphate.
Some of the polyphosphates tested, such as ATP, thiaminepyrophosphate, and pyrophosphate occur physiologically.
Others, such as the long-chain inorganic polyphosphates might be derived exogenously since the food industry has begun to use them as preservatives.
These findings corroborate and explain results obtained by Gutman and Yu (22) , showing that pyrophosphates, ADP and ATP, but not AMP, block in vitro calcification of cartilage. They are also in accord with a report of Thomas and Howard (18) stating that the addition of hexametaphosphate to urine prevents the mineral-ization of rat cartilage incubated therein. They are, however, in contradiction with the findings of Cartier (23) and Perkins and Walker (24) that ATP favors mineralization in vitro of cartilage.
In this connection it must be emphasized that the nucleation system presently used is nonvital, and that only physiological amounts of Ca, Pi, and polyphosphates were tested. These results suggest a new role for the action of phosphatase: not the formation of an activating substance, but the destruction of an inhibitor, perhaps a polyphosphate. They also help to explain why some collagen does not calcify in the body, but does mineralize in vitro at a physiological Ca: P product. The inhibitor present in plasma prevents calcium phosphate precipitation on the collagen fibrils, and it is only where this inhibitor is inactivated locally by the phosphatases that the salt can deposit. With this view in mind, it is encouraging to find that ossifiable cartilage and bone contain enzymes which destroy polyphosphates (24) (25) (26) . However, it is somewhat puzzling that polyphosphatases have also been demonstrated in other sites such as kidney and intestine (27) .
